Combination therapy may be better than radiotherapy alone to treat aggressive brain cancerFebruary 26, 2016
(PHILADELPHIA) -- Radiotherapy effectively damages brain tumors but the cancer cells can repair themselves in order to live on. Now, researchers at Sidney Kimmel Cancer Center have tested a strategy that combines radiotherapy with a drug that shuts down the ability of tumor to mend themselves.
Researchers say their 12-patient study, published Jan. 29, 2016 online ahead of print in the Journal of Neuro-Oncology, offer enough promise that a more comprehensive, phase 2 clinical trial should be conducted to test the combination therapy for aggressive, recurrent brain cancer.
"We saw synergy between radiotherapy and the agent, panobinostat. Our findings suggest panobinostat makes radiotherapy much more effective," says the study's senior author, Yaacov R. Lawrence, M.D., of the Department of Radiation Oncology at Thomas Jefferson University's Sidney Kimmel Medical College.
All 12 patients tested had high grade gliomas that had recurred after initial radiotherapy. Eight patients had recurrent glioblastoma, and four had recurrent anaplastic astrocytoma. These two forms of aggressive brain cancer represent almost 70 percent of newly diagnosed gliomas, which are diagnosed in about 10,000 patients annually. Despite response to initial radiation, most patients relapse within two years and overall survival is then limited to a year or less.
"There is no standard treatment for recurrent high grade gliomas. At Jefferson, we have a lot of experience with offering a second course of radiation after a patient relapses, in order to increase survival, but we are excited by the promise of a targeted agent that makes initial and repeat radiotherapy more effective," says co-author Adam Dicker, M.D., Ph.D., FASTRO, Chair and Professor of Radiation Oncology, Pharmacology and Experimental Therapeutics at the Sidney Kimmel Medical College.
Panobinostat, approved for use in 2015 for treatment of multiple myeloma, is being tested in a variety of other cancers. It is a histone deacetylase inhibitor that has been shown to modify expression of about eight percent of RNA molecules produced from genes. Modifying RNA changes protein production, unsetting cancer growth. The drug also turns off RAD51, a DNA repair enzyme, Dr. Dicker says.
Researchers found that the highest dose of panobinostat tested in patients was well tolerated, and they observed improved progression-free survival and overall survival.
"The intent of this study was not to demonstrate benefit of the combination therapy, but to test safety. Still, we did note promising activity, which must be validated in further studies," Dr. Lawrence says.
The study was funded by Novartis, which developed panobinostat. This funding was to the Sidney Kimmel Cancer Center. No author reports a conflict of interest.
Article Reference: Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas. Shi W, Palmer JD, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Bar-Ad V, Judy K, Farrell C, Simone N, Liu H, Dicker AP, Lawrence YR. J Neurooncol. Jan. 29, 2016. [Epub ahead of print] PMID: 26821711
For more information, contact:
Our newly formed organization, Jefferson, encompasses Thomas Jefferson University and Jefferson Health, representing our academic and clinical entities. Together, the people of Jefferson, 19,000 strong, provide the highest-quality, compassionate clinical care for patients, educate the health professionals of tomorrow, and discover new treatments and therapies that will define the future of health care.
Jefferson Health comprises five hospitals, 17 outpatient and urgent care locations, as well as physician practices and everywhere we deliver care throughout the city and suburbs across Philadelphia, Montgomery and Bucks Counties in Pa., and Camden County in New Jersey. Together, these facilities serve nearly 73,000 inpatients, 239,000 emergency patients and 1.7 million outpatient visits annually. Thomas Jefferson University Hospital is the largest freestanding academic medical center in Philadelphia. Abington Hospital is the largest community teaching hospital in Montgomery or Bucks counties. Other hospitals include Jefferson Hospital for Neuroscience in Center City Philadelphia; Methodist Hospital in South Philadelphia; and Abington-Lansdale Hospital in Hatfield Township.
Thomas Jefferson University enrolls more than 3,800 future physicians, scientists, nurses and healthcare professionals in the Sidney Kimmel Medical College (SKMC), Jefferson Colleges of Biomedical Sciences, Health Professions, Nursing, Pharmacy, Population Health and is home of the National Cancer Institute (NCI)-designated Sidney Kimmel Cancer Center.
For more information and a complete listing of Jefferson services and locations, visit http://www.jefferson.edu.
Thomas Jefferson University
Related Cancer Cells Articles:
Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
A gene previously identified as critical for tumor growth in many human cancers also maintains intestinal stem cells and encourages the growth of cells that support them, according to results of a study led by Johns Hopkins researchers.
Advanced prostate cancer and high blood cholesterol have long been known to be connected, but it has been a chicken-or-egg problem.
Princess Margaret Cancer Centre scientists have discovered a distinct cell population in tumours that inhibits the body's immune response to fight cancer.
Researchers have developed an artificial structure that mimics the cell membrane, which can switch on immune cells to attack and destroy a designated target.
Researchers have identified a unique subset of these cells that exhibit hybrid characteristics of two immune cell types -- neutrophils and antigen-presenting cells -- in samples from early-stage human lung cancers.
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Tiny bubbles filled with the sleep hormone melatonin can make breast cancer treatment more effective, which means people need a lower dose, giving them less severe side effects.
Baylor College of Medicine researchers report a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Related Cancer Cells Reading:
Essential Oils And Cancer: How To Effectively Use The Right Essential Oils To Confuse And Kill Cancer Cells
by Nancy Dennett Ducharme (Author)
Essential oils have been used for centuries to help support the immune system and bring the body back to health. This first book in the Essential Oils And Cancer series shows step by step exactly how to use essential oils to fight cancer. Learn how to prepare and use the compounds in two specific plant species to attack and destroy abnormal cells and cell mutations that have grown out of control. Learn which combinations of essential oils to use with breast cancer, bone cancer, lung cancer, skin cancer, prostate cancer, and other cancers according to latest scientific research. View Details
One Renegade Cell: How Cancer Begins (Science Masters Series)
by Robert A. Weinberg (Author)
Cancer research has reached a major turning point, and no one is better qualified to explain the past two deacades' dramatic leaps forward in understanding this disease than world-renowned molecular biologist Robert Weinberg, director of the Oncology Research Laboratory at the Whitehead Institute in Cambridge, Massachusetts. In One Renegade Cell, Weinberg presents a state-of-the-art account of how cancer begins and how, one day, it will be cured. View Details
NCCN Guidelines for Patients®: Lung Cancer (Non-Small Cell), Version 1.2016
by National Comprehensive Cancer Network® (NCCN®) (Author)
[OFFICIAL CURRENT VERSION] From the medical leaders of 27 of the world’s most renowned cancer centers united under the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to lung cancer (non-small cell lung cancer). Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients® are packed with the latest information, treatment innovations, and resources about the diagnosis and treatment of lung cancer. Each patient-friendly chapter prepares patients and caregivers to talk with their... View Details
How To Kill Cancer Cells: Make Your Body Healthy Now
by Natalie Mitchell (Author)
Natalie Mitchell’s Amazon Best Seller second book “How To Kill Cancer Cells” sets out clear guidelines for readers to create a bodily environment in which cancer cells cannot thrive. Everybody has cancer cells and with the medical technology available nowadays doctors can only diagnose cancer disease when people already have developed BILLIONS of active cancer cells in their body. While the information itself is easy to understand, the Author’s clear message is that we, as individuals, can control our susceptibility to Cancer, eliminate Cancer cells and prevent and avoid the disease... View Details
The 20 herbs that can kill the cancer cells: For every person who believes that herbs and plants can slow or even kill cancer
Cаnсеr is unсоntrоllеd grоwth of аbnоrmаl сеllѕ in thе body. Normally, mеiоѕiѕ аnd cell death рrосеdurе occurs to рrоtесt stable соnditiоn оf tiѕѕuеѕ in bаlаnсеd state. Cаrсinоgеnеѕiѕ is a multiѕtаgе оr multi mесhаniѕm procedure. Thе initiаl ѕtаgе оf саnсеr inсludеѕ irrеvеrѕiblе сеll changes.
Mоrе and more people who have been diаgnоѕеd with саnсеr оr rеlаtеd illnesses еmbrасе alternative medicines, аnd ѕееk оut hоliѕtiс рrасtitiоnеrѕ whо use vitаminѕ, herbs, nutrition,... View Details
Cancer: The Outlaw Cell
by Richard LaFond (Editor)
We live in an era in which scientific information grows by the day and is so specialized that no one person can possibly absorb and kept abreast of the literature. Substantial developments in science and medicine, powered by developing technologies such as genetic sequencing, proteomics, and nanobiology, have driven cancer research forward, and a review of where we are now is desperately needed.
Cancer: The Outlaw Cell is a collection of twenty-five focused chapters written by leading researchers at the forefront of cancer research. Authors present the current state of... View Details
Small Cell Lung Cancer - Treatment Options and Alternative Medicine
by Christian Vazquez (Author)
Small Cell Lung Cancer is a full crash course on the topic. We reviewed over 300 of the strongest natural agents that exist for cancer and found only 6 that have conclusive evidence for small cell lung cancer. The biggest problem is not lack of information in the world, it is the lack of time, understanding of the medical data associated with scientific research and to top it off there is so much data in so many directions between the pharmaceutical, people trying to steer you in the wrong way to make a quick dollar, the quacks of the industry and everything else imaginable where at the end... View Details
The Cancer Fighting Diet: Diet and Nutrition Strategies to Help Weaken Cancer Cells and Improve Treatment Results
by Dr. Johannes Coy Sc.D. (Author), Maren Franz (Author)
This book provides basic information about cancer, as well as detailed advice and a comprehensive diet plan to help fight a personal battle with cancer and significantly improve chances of a cure.
There are complex processes inside the human body and specific mechanisms that can lead to the development and spread of cancer cells. Understanding the causes for what is happening inside the body is the key to implementing the recommendations in this guide.
Using these recipes and nutritional strategies will cut dramatically down on sugar in order to deplete the strength and... View Details
Anticancer: A New Way of Life
by David Servan-Schreiber MD PhD (Author)
The revolutionary, New York Times bestselling guide to the powerful lifestyle changes that fight and prevent cancer—an integrative approach based on the latest scientific research
“A common-sense blueprint for healthy living.” —Chicago Tribune
“Resonating with cancer support communities and recommended nationwide.” —Los Angeles Times
“Life affirming . . . filled with practical advice.” —The Seattle Times
David Servan-Schreiber was a rising... View Details
The Immortal Life of Henrietta Lacks
by Rebecca Skloot (Author)
Now an HBO® Film starring Oprah Winfrey and Rose Byrne
#1 NEW YORK TIMES BESTSELLER
Her name was Henrietta Lacks, but scientists know her as HeLa. She was a poor black tobacco farmer whose cells—taken without her knowledge in 1951—became one of the most important tools in medicine, vital for developing the polio vaccine, cloning, gene mapping, and more. Henrietta's cells have been bought and sold by the billions, yet she remains virtually unknown, and her family can't afford health insurance. This phenomenal New York Times bestseller tells a riveting story... View Details